Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)
ID: 354792Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354792

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-027.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Jun 7, 2024 12:00 AM
  4. 4
    Due Oct 11, 2024 12:00 AM
Description

The National Institutes of Health (NIH) has posted a grant opportunity titled "Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)". This grant aims to support multi-level intervention studies that address individual and system level barriers to transition from pediatric to adult care for survivors of childhood and adolescent cancers. The goal is to develop and test interventions and strategies that promote high-quality transitional care and continued engagement of survivors to ensure they receive appropriate surveillance and care into adulthood. The research funded through this grant will provide critical evidence for establishing best practices and standards of care that can be widely disseminated and adopted. For more information, visit the NIH Grants website.

Point(s) of Contact
grantsinfo@nih.gov
Files
No associated files provided.
Similar Opportunities
Notice of Intent to Publish a Funding Opportunity Announcement for Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a funding opportunity announcement (FOA) for addressing barriers to healthcare transitions for survivors of childhood and adolescent cancers. This FOA aims to support multi-level intervention studies that address individual and system level barriers to transitions from pediatric to adult care for these survivors. The goal is to develop and test interventions and strategies that promote high-quality transitional care and continued engagement of survivors to ensure appropriate surveillance and care into adulthood. The anticipated outcome of this research is to establish best practices and standards of care that can be widely disseminated and adopted. The FOA is associated with the STAR Reauthorization Act of 2023, which focuses on maximizing and accelerating the availability of promising models of care for pediatric cancer survivors. The FOA is expected to be published in June 2024, with an application due date in October 2024. It will utilize the R01 activity code.
Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)". This grant aims to support the assessment of barriers to quality cancer treatment and follow-up care for sexual and gender minority (SGM) cancer survivors. The grant seeks proposals for observational and/or interventional studies of SGM survivors to understand barriers and improve care and outcomes for SGM individuals with cancer. The studies should utilize interoperable sexual orientation and gender identity (SOGI) data collection in cancer care settings. The grant does not require cost sharing or matching. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The deadline for application submission is January 7, 2027. For more information and to apply, visit the following link: [Additional Information](http://grants.nih.gov/grants/guide/pa-files/PAR-23-292.html). For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)". This grant aims to address barriers and facilitators that impede the use or uptake of cancer screening and preventive services in populations that experience health disparities. The interventions should include screening, preventive services, or other healthcare processes, including timely follow-up of abnormal findings and referral to accessible care. The projects are encouraged to collaborate with community partners and service providers. The interventions should target barriers and facilitators at the patient, clinician, healthcare setting, and neighborhood/community levels. For more information and to apply, visit the following link: [Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)](http://grants.nih.gov/grants/guide/pa-files/PAR-23-170.html).
The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)" in the category of Health. This grant aims to support the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. The grant provides protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position. The grant does not require cost sharing or matching requirements. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs), among others. Non-domestic (non-U.S.) entities and components are not eligible to apply. The closing date for this grant opportunity is March 12, 2027. For more information and to apply, please visit the following link: [NCI Transition Career Development Award Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-24-117.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)". This grant aims to support the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials. It also includes correlative studies associated with clinical trials, novel cancer therapeutic, symptom/toxicity, and preventive agent development, radiotherapy development activities, and mechanism-driven combinations. Additionally, innovative preclinical studies, including the use of new clinically-relevant models and imaging technologies, are encouraged, as they could lead to first-in-human clinical trials. The R21 mechanism provides support for the early and conceptual stages of these projects, which may involve considerable risk but have the potential to make breakthroughs in cancer research. The grant has a funding ceiling of $275,000 and does not require cost sharing or matching. The opportunity is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), non-domestic (non-U.S.) entities (Foreign Organizations), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territories or Possessions. The closing date for applications is July 1, 2025. For more information and to apply, visit the following link: [NCI Clinical and Translational Exploratory/Developmental Studies Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-22-216.html).